Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

BCTX BriaCell Therapeutics Corporation

0.10 (7.30%)
May 29 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
BriaCell Therapeutics Corporation BCTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.10 7.30% 1.47 19:53:49
Open Price Low Price High Price Close Price Prev Close
1.38 1.3178 1.53 1.54 1.37
more quote information »

Recent News

Date Time Source Heading
5/28/202408:00GLOBEBriaCell Announces Clinical Supply Agreement with BeiGene..
5/24/202408:00GLOBEBriaCell Doubles Progression-Free-Survival (PFS) and Reports..
5/17/202416:33GLOBEBriaCell Therapeutics Announces Closing of $5.0 Million..
5/15/202408:00GLOBEBriaCell Therapeutics Announces Pricing of $5.0 Million..
4/24/202408:00GLOBEBriaCell Announces Oral and Poster Presentations at ASCO..
4/10/202408:00GLOBEBriaCell 2024 AACR Preclinical Poster Confirms Strong..
4/09/202408:00GLOBEBriaCell Showcases Data Demonstrating Unmatched..
3/07/202408:00GLOBEBriaCell Receives and Executes Letter of Intent to Advance..
3/06/202408:00GLOBEBriaCell to Present Clinical Data in Central Nervous System..
2/27/202408:00GLOBEBriaCell Provides Update on Alleged Illegal Trading of..
2/07/202408:00GLOBEBriaCell Announces Strong Clinical Data in Breast Cancer..
2/06/202408:30GLOBEBreaking Ground in Prostate Cancer: BriaCell Announces Lead..
2/01/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
1/31/202417:24EDGAR2Form 8-K - Current report
1/30/202422:48GLOBEBriaCell Therapeutics Corp. Announces Results of Shareholder..
1/22/202417:00EDGAR2Form S-3 - Registration statement under Securities Act of..
1/09/202416:05EDGAR2Form DEF 14A - Other definitive proxy statements
1/04/202408:45GLOBEBriaCell Images Confirm Robust Anti-Tumor Activity in..
12/28/202308:55GLOBEBriaCell Reports 71% Central Nervous System Response Rate in..
12/20/202316:05EDGAR2Form 8-K - Current report
12/20/202308:40GLOBEBriaCell Reports Unprecedented Preliminary Survival and..
12/14/202317:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/14/202317:00EDGAR2Form 8-K - Current report
12/06/202309:31GLOBEBriaCell Highlights Outstanding Topline Survival and..
12/06/202309:00GLOBEBriaCell 2023 SABCS Posters Confirm Activation of..
11/30/202307:00EDGAR2Form 8-K - Current report
11/30/202307:00GLOBEBriaCell Records New Responder with Remarkable Improvement..
11/03/202308:31GLOBEBriaCell Reports Unprecedented Anti-Tumor Activity of its..
10/25/202309:15GLOBEBriaCell Forms Medical Advisory Board of Distinguished..
10/20/202309:15GLOBEOctober is Breast Cancer Awareness Month – BriaCell is..
10/18/202309:00GLOBEBriaCell Announces Presentations at the 2023 Society for the..
10/11/202309:10GLOBEBriaCell To Host Virtual Key Opinion Leader Event on..
10/04/202309:00GLOBEBriaCell Partners with New York Cancer & Blood Specialists..
10/03/202309:00GLOBEBriaCell Initiates Pivotal Phase 3 Study of Bria-IMT™ in..
9/08/202307:00GLOBEBriaCell Reports Benchmark-Beating Patient Survival and..
8/31/202311:54GLOBEBriaCell Therapeutics Corp. Announces Closing of Plan of..
8/31/202308:21GLOBEBriaCell Accepts Letter of Intent from Weill Cornell..
8/25/202314:33GLOBEBriaCell Receives Court Approval for the Share Arrangement..
8/18/202312:21GLOBEBriaCell Therapeutics Corp. Announces Voting Results From..
8/16/202308:36GLOBEBriaCell Awarded National Cancer Institute Grant to Advance..
6/27/202309:37APSNews Brief: BriaCell Therapeutics Corp.
6/27/202308:05GLOBEFDA Approves BriaCell’s Pivotal Registrational Study Design..

Your Recent History

Delayed Upgrade Clock